Literature DB >> 2478362

2-Aminopurine selectively blocks the transcriptional activation of cellular genes by virus, double-stranded RNA and interferons in human cells.

M G Wathelet1, I M Clauss, F C Paillard, G A Huez.   

Abstract

Interferons, double-stranded RNA and viruses induce the transcription of partly overlapping sets of cellular genes. We have studied the regulation of 11 interferon-inducible genes by these agents and found that four of them were also directly inducible by virus and double-stranded RNA, and two by virus only. We have investigated whether an inhibitor of interferon-beta gene activation, 2-aminopurine, would block this induction process. Induction of these genes by virus and double-stranded RNA was indeed blocked by 2-aminopurine. Since a single cis-acting element can confer inducibility both to interferons, and to virus and double-stranded RNA, we tested the effect of 2-aminopurine on gene activation by interferon-alpha and interferon-gamma. Remarkably, in all the cell lines tested, these induction processes and the establishment of an antiviral state were blocked by the drug. These observations contrast with previous reports. The inhibitory effect of this drug on gene induction was exerted in a selective fashion and at the transcriptional level. This indicate that for the virus-, double-stranded-RNA-, and interferons-mediated gene induction, an early and similar step in signal transduction was affected by 2-aminopurine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478362     DOI: 10.1111/j.1432-1033.1989.tb15043.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  A cis-acting element in the 3'-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR.

Authors:  F Osman; N Jarrous; Y Ben-Asouli; R Kaempfer
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

2.  Gene induction by interferons: functional complementation between trans-acting factors induced by alpha interferon and gamma interferon.

Authors:  S K Bandyopadhyay; D V Kalvakolanu; G C Sen
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

3.  Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element.

Authors:  C Daly; N C Reich
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

4.  Evidence for involvement of protein kinase C in the cellular response to interferon alpha.

Authors:  N C Reich; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

Authors:  G R Foster; A M Ackrill; R D Goldin; I M Kerr; H C Thomas; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

6.  2-Aminopurine selectively inhibits splicing of tumor necrosis factor alpha mRNA.

Authors:  N Jarrous; F Osman; R Kaempfer
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase.

Authors:  G S Feng; K Chong; A Kumar; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

8.  Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis.

Authors:  N Watanabe; J Sakakibara; A G Hovanessian; T Taniguchi; T Fujita
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

9.  Identification of differentially expressed genes in blood cells of narcolepsy patients.

Authors:  Susumu Tanaka; Yutaka Honda; Makoto Honda
Journal:  Sleep       Date:  2007-08       Impact factor: 5.849

10.  Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells.

Authors:  L M Pfeffer; B L Eisenkraft; N C Reich; T Improta; G Baxter; S Daniel-Issakani; B Strulovici
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.